<DOC>
	<DOCNO>NCT02914379</DOCNO>
	<brief_summary>The purpose study measure much LY3337641 get bloodstream long take body get rid . In addition , safety tolerability study drug evaluate . Participants admit clinical research unit ( CRU ) day dose . Participants remain confined CRU least 7 day . Participants may discharge CRU time 7 day post-dose ( Day 8 ) , maximum 21 day post-dose ( Day 22 ) . This study last approximately 30 day participant , include screen . Screening require within 28 day prior start study .</brief_summary>
	<brief_title>A Study LY3337641 Healthy Male Participants</brief_title>
	<detailed_description />
	<criteria>Overtly healthy male , determine medical history physical examination Have body mass index ( BMI ) 18.5 32.0 kilogram per meter square ( kg/m² ) Have clinical laboratory test result within normal reference range population investigative site , result acceptable deviation judge clinically significant investigator Have venous access sufficient allow blood sample per protocol Are able willing give sign informed consent Generally minimum 1 bowel movement per day Have participate , within last 30 day , clinical trial involve investigational product . If previous investigational product long halflife , 3 month 5 halflives ( whichever longer , know ) pass Have significant history current cardiovascular , respiratory , hepatic , renal , gastrointestinal ( GI ) ( cholecystectomy acceptable ) , endocrine , hematological , dermatologic , neurological disorder capable significantly alter absorption , metabolism , elimination drug ; constitute risk take investigational product ; interfere interpretation data Regularly use know drug abuse and/or show positive finding urinary drug screening Have use intend use overthecounter prescription medication , include herbal medication , within 14 day prior dose Have donate blood 500 milliliter ( mL ) within month prior screen Have average weekly alcohol intake exceed 21 unit per week , unwilling stop alcohol consumption 48 hour prior admission , resident clinical research unit ( CRU ) In opinion investigator sponsor , unsuitable inclusion study Have exposure significant diagnostic , therapeutic , employment relate radiation within 12 month prior dose ( serial xray compute tomography scan , barium meal , current employment job require radiation exposure monitoring ) Have participate [ ¹⁴C ] study within last 6 month prior admission study . The total 12month exposure study maximum one previous [ ¹⁴C ] study within 6 12 month study must within Code Federal Regulations ( CFR ) recommend level consider safe ( per 21 CFR 361.1 ) : le 5000 Millirem ( mrem ) /year whole body annual exposure</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>